We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Antibodies in Research: The Good, the Bad, and the Validation Epidemic

Article   Apr 29, 2019 | by Anthony Couvillon, Ph.D., Scientific Marketing Project Manager at Cell Signaling Technology

 
Antibodies in Research: The Good, the Bad, and the Validation Epidemic
 
 
 

RELATED ARTICLES

What is Pharmacovigilance?

Article

Pharmaceutical drugs are a valuable part of patient care throughout the world. For doctors to adequately care for their patients, drug safety must be monitored and reported from initial testing to everyday use. In this article, we explore the world of pharmacovigilance.

READ MORE

The Neuroscience of Psychedelic Drugs: Octopuses, MDMA and Healing Social Injury

Article

In our latest interview series, we discuss the potential of psychedelics to revolutionize clinical neuroscience with thought leaders in the field. In this first interview of our series exploring the Neuroscience of Psychedelics, we talk to Johns Hopkins Associate Professor Gul Dölen, who has spent years exploring the effects of MDMA on the mammalian (and more recently, cephalopod) brain.

READ MORE

Cutting Through the Headlines: Are Scientists Really Growing Sentient "Mini-brains"?

Article

Neuroscience 2019, the world’s biggest conference of brain science, finished just over a month ago. In the wake of some particularly inflammatory headlines, we take a closer look at whether claims that new model systems for studying the brain could produce sentience in a jar have any truth to them.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science Diagnostics Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE